GlassScriptPhysician profile
Paul Anthony Tucker
NPI 1134104847
$15,385.90
in general payments reported to CMS, 2019-2025
46 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,018 · 2020: $3,533 · 2021: $3,533 · 2022: $1,590 · 2023: $1,777 · 2024: $1,630 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,712.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osprey Medical INC | $4,078.95 | 2019-2021 | |
| Amgen INC. | $1,629.33 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,539.24 | 2019-2025 | |
| Novo Nordisk INC | $900.40 | 2021-2025 | Ozempic, Rybelsus |
| Shockwave Medical, INC | $823.25 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $656.58 | 2019-2024 | Xarelto |
| Abiomed | $506.19 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $500.07 | 2019-2024 | Brilinta, Farxiga |
| Pfizer INC. | $470.83 | 2020-2025 | |
| Medtronic, INC. | $452.49 | 2021-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Regeneron Healthcare Solutions, INC. | $402.09 | 2019-2025 | Evkeeza, Praluent |
| Atricure, INC. | $354.79 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $315.46 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $297.37 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $226.03 | 2019-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.